Laboratoire de Bioimagerie et Pathologies


Logo Universite de strasbourg


Sur ce site

Sur le Web du CNRS

Accueil du site > Equipe Signalisation tumorale et cibles thérapeutiques > Publications

Publication 2013

2 février 2015

D. AKCORA, D. HUYNH, S. LIGHTOWLER, M. GERMANN, S. ROBINE, J.R. de MEY, J.W. POLLARD, R. STANLEY, J. MALATERRE & R.G. RAMSAY. The CSF-1 receptor fashions the intestinal stem cell niche. Stem Cell Res. 10, 203-212, 2013 – IF 4.38

G. CARRE, D. BENHAMIDA, J. PELUSO, C.D. MULLER, M.C. LETT, J.P. GIES, V. KELLER, N. KELLER & P. ANDRE. On the use of capillary cytometry for assessing the bactericidal effect of TiO2. Identification and involvement of reactive oxygen species. Photochem. Photobiol. Sci. 12, 610-620, 2013 – IF 2.79

L. CHOULIER, Y. NOMINE, G. ZEDER-LUTZ, S. CHARBONNIER, B. DIDIER, M.L. JUNG & D. ALTSCHUH. Chemical library screening using a SPR-based inhibition in solution assay : simulations and experimental validation. Anal. Chem. 85, 8787-8795, 2013 – IF 5.97

M. DUVAL, A. KOREPANOV, O. FUCHSBAUER, P. FECHTER, A. HALLER, A. FABBRETTI, L. CHOULIER, R. MICURA, B.P. KLAHOLZ, P. ROMBY, M. SPRINGER & S. MARZI. Escherichia coli ribosomal protein S1 unfolds structured mRNAs onto the ribosome for active translation initiation. PLoS Biol. 11, e1001731, 2013 – IF 12.81

J. DE MEY & J.N. FREUND. Understanding epithelial homeostasis in the intestine : an old battlefield of ideas, recent breakthroughs and remaining controversies. Tissue Barriers 1, e24965, 2013 – IF n.a.

H. JANOUSKOVA, A.M. RAY, F. NOULET, I. LELONG-REBEL, L. CHOULIER, F. SCHAFFNER, M. LEHMANN, S. MARTIN, J. TEISINGER & M. DONTENWILL. Activation of p53 pathway by Nutlin-3a inhibits the expression of the therapeutic target α5 integrin in colon cancer cells. Cancer Lett. 336, 307-318, 2013 – IF 4.88

M. KRIFA, M. ALHOSIN, C.D. MULLER, J.P. GIES, L. CHEKIR-GHEDIRA, K. GHEDIRA, Y. MELY, C. BRONNER* & M. MOUSLI* (*equal contributors). Limoniastrum guyonianum aqueous gall extract induces apoptosis inhuman cervical cancer cells involving p16INK4A re-expression related to UHRF1 and DNMT1 down-regulation. J. Exp. Clin. Cancer Res., 32, 30, 2013 – IF 3.10

M. RABINEAU, L. KOCGOZLU, D. DUJARDIN, B. SENGER, Y. HAIKEL, J.C. VOEGEL, J.N. FREUND, P. SCHAAF, P. LAVALLE & D. VAUTIER. Contribution of soft substrates to malignancy and tumor suppression during colon cancer cell division. PLoS ONE 8, e78468, 2013 – IF 4.01

F. SCHAFFNER, A.M. RAY & M. DONTENWILL. Integrin α5β1, the fibronectin receptor, as a pertinent therapeutic target in solid tumors. Cancers 5, 27-47, 2013 – IF n.a.

F. SCHAFFNER, N. YOKOTA, T. CARNEIRO-LOBO, M. KITANO, M. SCHAFFER, G.M. ANDERSON, B.M. MUELLER, C.T. ESMON & W. RUF. Endothelial protein C receptor function in murine and human breast cancer development. PLoS ONE 8, e61071, 2013 – IF 4.01

I. YOUGBARÉ, G. BOIRE, M. ROY, C. LUGNIER & E. ROUSSEAU. NCS 613 exhibits anti-inflammatory effects on PBMCs from lupus patients by inhibiting p38 MAPK and NF-κB signalling pathways while reducing proinflammatory cytokine production. Can. J. Physiol. Pharmacol. 91, 353-361, 2013 – IF 1.74